Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More…
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
CIKN/A
Phone855-558-9333
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$170.25 million
Profitability
Miscellaneous
Employees3,200
Next Earnings Date2/13/2020 (Estimated)
OptionableOptionable
Canopy Growth (NYSE:CGC) Frequently Asked Questions
What is Canopy Growth's stock symbol?
Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."
When is Canopy Growth's next earnings date?
What price target have analysts set for CGC?
19 Wall Street analysts have issued 12 month price targets for Canopy Growth's stock. Their forecasts range from $17.00 to $107.57. On average, they anticipate Canopy Growth's share price to reach $46.96 in the next year. This suggests a possible upside of 206.3% from the stock's current price. View Analyst Price Targets for Canopy Growth.
What is the consensus analysts' recommendation for Canopy Growth?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings, 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Canopy Growth.
Has Canopy Growth been receiving favorable news coverage?
News headlines about CGC stock have been trending somewhat negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Canopy Growth earned a news impact score of -1.4 on InfoTrie's scale. They also gave media coverage about the marijuana producer a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Canopy Growth.
Who are some of Canopy Growth's key competitors?
Some companies that are related to Canopy Growth include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), OrganiGram (OGI), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), KushCo (KSHB), Bioventix (BVXP), GrowGeneration (GRWG), Nemus Bioscience (NMUS), Terra Tech (TRTC), United Cannabis (CNAB), General Cannabis (CANN), mCig (MCIG) and Grow Capital (GRWC).
What other stocks do shareholders of Canopy Growth own?
Who are Canopy Growth's key executives?
Canopy Growth's management team includes the folowing people:
- Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
- Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
- Mr. Timothy Rob Saunders, Exec. Officer
- Mr. Rade Kovacevic, Exec. VP
- Mr. Mike Lee, Acting Chief Financial Officer
Who are Canopy Growth's major shareholders?
Canopy Growth's stock is owned by a number of of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.22%), Commonwealth Equity Services LLC (0.09%), Cambridge Investment Research Advisors Inc. (0.06%), CIBC Asset Management Inc (0.05%), Great West Life Assurance Co. Can (0.05%) and Commerzbank Aktiengesellschaft FI (0.04%).
Which institutional investors are selling Canopy Growth stock?
CGC stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Jupiter Wealth Management LLC, Sumitomo Mitsui Trust Holdings Inc., Sheaff Brock Investment Advisors LLC, Oppenheimer & Co. Inc., Sigma Planning Corp, K.J. Harrison & Partners Inc and Usca Ria LLC.
Which institutional investors are buying Canopy Growth stock?
CGC stock was acquired by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Exane Derivatives, Venturi Wealth Management LLC, Cambridge Investment Research Advisors Inc., Lau Associates LLC, Avitas Wealth Management LLC, Valeo Financial Advisors LLC and Commonwealth Equity Services LLC.
How do I buy shares of Canopy Growth?
Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Canopy Growth's stock price today?
One share of CGC stock can currently be purchased for approximately $15.33.
How big of a company is Canopy Growth?
Canopy Growth has a market capitalization of $5.34 billion and generates $170.25 million in revenue each year. The marijuana producer earns $-522,300,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. Canopy Growth employs 3,200 workers across the globe.View Additional Information About Canopy Growth.
What is Canopy Growth's official website?
How can I contact Canopy Growth?
Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A 0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]
MarketBeat Community Rating for Canopy Growth (NYSE CGC)
MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days.
